[{"Assets_0_Q2_USD":285807000.0,"CommonStockSharesOutstanding_0_Q2_shares":381683985.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-106046000.0,"NetIncomeLoss_1_Q2_USD":-44492000.0,"NetIncomeLoss_2_Q2_USD":-90844000.0,"StockholdersEquity_0_Q2_USD":-87707000.0,"Ticker":"NVAX","CIK":"1000694","name":"NOVAVAX INC","OfficialName":"Novavax Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4164288206.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180808"}]